Guidance for Developers of Health Research Reporting Guidelines
Open accessThe DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index; 5 of the 25 sources its claims cite were checked for support.
Abstract
David Moher and colleagues from the EQUATOR network offer guidance and recommended steps for developing health research reporting guidelines.
Overview
CoChat Summary
## TL;DR
This paper provides an 18-step, five-phase framework for developing health research reporting guidelines, based on the authors’ collective experience and examples from guideline projects such as CONSORT, STARD, STROBE, PRISMA, and SPIRIT. It argues that reporting guidelines should be developed using explicit methodology, consensus, literature review, and post-publication implementation and updating strategies.
## Key findings
- The authors propose 18 steps arranged in five phases for reporting guideline development, including identifying need, reviewing the literature, pre-meeting activities, the face-to-face consensus meeting, and post-meeting/post-publication activities.
- They recommend a face-to-face meeting of no more than about 30 participants, lasting a minimum of one day; in their experience meetings have lasted one to three days.
- For funding, they recommend budgeting at least Can$10,000 for pre-meeting activities, about Can$75,000 for the main meeting, and at least Can$35,000 for a small writing group to draft new guidance with an explanation and elaboration document.
- In a survey of 30 respondents, 47% had received funds from a non-profit agency, 17% from the pharmaceutical industry, and 6% from government; the authors note that 83% of guideline developers recognize the need to update guidelines.
## Methods
- This is a guidance paper drawing on the authors’ collective experience of helping develop more than ten reporting guidelines over 16 years; it is not an empirical trial.
- The guidance is informed by examples from existing reporting guideline initiatives (e.g., CONSORT, STARD, STROBE, PRISMA, SPIRIT) and by cited evidence, including a systematic review of 81 reporting guidelines mentioned in the introduction.
- The main analytical approach is expert synthesis and consensus-based recommendation, organized into a stepwise framework for guideline development and implementation.
## Limitations
- The paper explicitly states that there is no single best or correct approach to reporting guideline development.
- It notes that the literature on how individual guidelines were developed remains sparse, and that to date, no published data inform the costs required to develop a reporting guideline.
- An evident limitation of the paper itself is that the recommendations are based largely on the authors’ experience and selected examples, rather than on a formal comparative evaluation of different development methods.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 Valid · 3 Not valid · 16 Not checked · 8 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Unfortunately, few guidelines appear to have been evaluated to date [24].”
§ Guidance for Developers of Health Research Reporting Guidelines > Post-publication Activities > 15. Evaluate the Impact of the Reporting Guidance
What the sources say
- Supportedcites [24] I Simera, 2008, Guidelines for reporting health research: the EQUATOR Network's survey of guideline authors., PLoS Med source
The Discussion reports that evaluations of guideline uptake or impact had been attempted for only eight (27%) guidelines in the survey. This supports the claim that few reporting guidelines had been evaluated. (LLM, conf=0.94)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“For example, recent empirical evidence [21] on outcome reporting bias led the CONSORT Group, when preparing CONSORT 2010, to add a checklist item specifically asking authors to describe any changes made to their study outcomes between the protocol and final analysis.”
§ Guidance for Developers of Health Research Reporting Guidelines > Post-publication Activities > 18. Update Guideline
What the sources say
- Supportedcites [21] K Dwan, 2008, Systematic review of the empirical evidence of study publication bias and outcome reporting bias., PLoS ONE source
The citation [21] is attached to 'recent empirical evidence ... on outcome reporting bias', and our copy is exactly that body of evidence: the Abstract (Methodology/Principal Findings) states 'In comparing trial publications to protocols, we found that 40–62% of studies had at least one primary outcome that was changed, introduced, or omitted', and the Results (Publication and trial findings, p. ~4) report the same with odds ratios 2.2–4.7 for complete reporting of significant outcomes. The Introduction likewise frames this as the direct empirical evidence for the existence of outcome reporting bias. The further step — that this evidence led the CONSORT Group to add a CONSORT 2010 checklist item on describing outcome changes — is the citing authors' own framing; our copy (2008, pre-dating CONSORT 2010) contains no passage about CONSORT 2010, and searches for 'CONSORT 2010 checklist item' and 'reporting guidelines/CONSORT statement' returned only a cited reference (Kane et al. 2007) and the Discussion's recommendation that 'Trialists should be encouraged to describe legitimate changes to outcomes stated in the protocol'. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As yet few reporting guidelines have been updated,”
§ Guidance for Developers of Health Research Reporting Guidelines > Post-publication Activities > 18. Update Guideline
What the sources say
- Supportedcites [24] I Simera, 2008, Guidelines for reporting health research: the EQUATOR Network's survey of guideline authors., PLoS Med source
The Discussion states that, as yet, only one guideline team—the CONSORT developers—had published a revision, although 25 others recognized the need to do so. This directly supports the claim that few reporting guidelines had been updated at the time of the survey. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“although most (83%) guideline developers recognize the need to do so [24].”
§ Guidance for Developers of Health Research Reporting Guidelines > Post-publication Activities > 18. Update Guideline
What the sources say
- Supportedcites [24] I Simera, 2008, Guidelines for reporting health research: the EQUATOR Network's survey of guideline authors., PLoS Med source
The Discussion (p. 3 of our copy) states that only the CONSORT team had published a revision, "although 25 (83%) others recognised the need to do so in due course", in the context of the need to regularly update reporting guidelines. The citing sentence's 83% figure and the subject (guideline developers recognising the need to update) match this passage exactly; the only minor nuance is that the paper phrases it as 83% of surveyed developers (25 of 30 respondents) recognising the need "in due course". (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“However, the quality of reporting in most health care journals remains inadequate.”
- Also stated in: § Introduction · boosted
“This is just one of numerous examples of a large and disturbing literature indicating the general failure in the quality of reporting health research [2]–[6].”
- Also stated in: § Introduction · plain
“Many publications lack clarity, transparency, and completeness in how the authors actually carried out their research.”
§ Guidance for Developers of Health Research Reporting Guidelines > Introduction
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · boosted
5 more claims
Create a free account to see all 32 claims and to verify the 20 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reporting guidelines outline a minimum set of items to include in research reports and have been shown to increase methodological transparency and uptake of research findings (8, 9).”
From PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, Moher et al. 20 reported that, although over 63,000 new studies are published in PubMed on a monthly basis, many publications face the problem of inadequate reporting.”
From A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given the lack of standardization and poor quality of reporting, the Enhancing the QUAlity and Transparency Of health Research (EQUATOR)Networkwascreated to help researchers publish high-impact health research. 20”
From A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These steps are crucial in developing guidelines as they help identify potential gaps and opinions of different experts in the field. 20, 24”
From A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) (2021) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence-based tools developed by experts could help streamline particular procedures that authors could follow to create reproducible and higher quality studies. 18 -20”
From A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) (2021) · cites this paper as [20]
Experimental — accuracy not yet measured
44 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Self-citationPreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“Our experience is that the journal submission and peer review processes for multiple simultaneous publications can be exhausting. Some steps can reduce the burden. For example, the guideline author group might want to nominate an author as corresponding author to facilitate the coordination process with the various jo…”
BackgroundSelf-citationPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Self-citationPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Self-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“The novel format of the CONSORT E&E was emulated for several later reporting guidelines—STARD, STROBE, and PRISMA [46–48].”
MethodSelf-citationvon Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Self-citationPreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Self-citationWang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Self-citationVandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Self-citationSchulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634 · cited 2×
“concealment as a checklist item of the original CONSORT Statement was based on an empirical study [20].”
MethodMoher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Self-citationThe Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835 · cited 1×
“That concern underpinned the decision of the CONSORT Group to accompany the revised CONSORT Statement [44] with a detailed explanatory document, which was named ‘‘Explanation and Elaboration’’ (E&E) [45].”
MethodSelf-citationConsort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510
Self-citationTowards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
Self-citationTowards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Self-citationVandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181577511 · Cited by 2,779
Self-citationMoher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Self-citationCONSORT statement: extension to cluster randomised trials
Campbell, M. K., Elbourne, D. R., & Altman, D. G. (2004) · BMJ · doi:10.1136/bmj.328.7441.702 · Cited by 2,557
Self-citationConsensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051 · cited 2×
“A consensus process [10] should be a crucial characteristic of developing a reporting guideline.”
BackgroundMethodSystematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003081 · Cited by 1,546 · cited 2×
“The new item on outcomes follows from empirical evidence [21] indicating that authors frequently do not provide analyses of outcomes in their published papers that were the prespecified outcomes in their protocols (i.”
BackgroundMethodSelf-citationClinical Trial Registration: A Statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejme048225 · Cited by 1,241
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058 · cited 1×
“The addition of a new trial registration item reflects current journal practice [22] stemming from some researchers hiding results of randomized trials [23].”
Fitzpatrick, R., Shortall, E., Sculpher, M. J., et al. (1998) · PubMed · Cited by 972
Fitzpatrick, Shortall, Sculpher, Murray, Morris, Lodge, Dawson, Carr, Britton, & Briggs (1998) · Health Technology Assessment · doi:10.3310/hta2200 · Cited by 969
Consensus development methods, and their use in clinical guideline development.
Murphy, M. P., Black, N. A., Lamping, D. L., et al. (1998) · PubMed · Cited by 965
Epidemiology and reporting characteristics of systematic reviews.
Moher, D., Tetzlaff, J., Tricco, A. C., Sampson, M., & Altman, D. G. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040078 · Cited by 891 · cited 1×
“This is just one of numerous examples of a large and disturbing literature indicating the general failure in the quality of reporting health research [2–6].”
BackgroundSelf-citationPlint, A. C., Moher, D., Morrison, A., Schulz, K., Altman, D. G., Hill, C., & Gaboury, I. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00557.x · Cited by 872
Self-citationTowards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Clinical Chemistry · doi:10.1373/49.1.1 · Cited by 862
Self-citationHow Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis
Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00179 · Cited by 838 · cited 1×
“The trigger to update is complex and likely similar to other areas of research [40].”
ResultSelf-citationLittle, J., Higgins, J. P. T., Ioannidis, J. P. A., Moher, D., Gagnon, F., von Elm, E., Khoury, M. J., Cohen, B., Davey-Smith, G., Grimshaw, J., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000022 · Cited by 811
Self-citationWhat is missing from descriptions of treatment in trials and reviews?
Glasziou, P., Meats, E., Heneghan, C., & Shepperd, S. (2008) · BMJ · doi:10.1136/bmj.39590.732037.47 · Cited by 614 · cited 1×
“Glasziou and colleagues [1] assessed descriptions of given treatments in 80 trials and systematic reviews for which summaries were published during one year (October 2005 to October 2006) in Evidence-Based Medicine, a journal that is aimed at physicians working in primary care and general medicine.”
BackgroundReporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement
Gagnier, J. J., Boon, H., Rochon, P., Moher, D., Barnes, J., Bombardier, C., & for the CONSORT Group* (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00013 · Cited by 608 · cited 1×
“For limited extensions a single article may best cover both roles, as was done, for example, for CONSORT for herbal interventions [27] and CONSORT for NPT [18].”
MethodSelf-citationBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008-w1 · Cited by 523
Self-citationNon-communicable diseases must have greater priority, says WHO
Zarocostas, J. (2009) · BMJ · doi:10.1136/bmj.b2857 · Cited by 517
Epidemiology and reporting of randomised trials published in PubMed journals
Chan, A.-W., & Altman, D. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71879-1 · Cited by 474 · cited 1×
“This is just one of numerous examples of a large and disturbing literature indicating the general failure in the quality of reporting health research [2–6].”
BackgroundSelf-citationCONSORT for reporting randomised trials in journal and conference abstracts
Hopewell, S., Clarke, M., Moher, D., Wager, E., Middleton, P., Altman, D. G., & Schulz, K. F. (2008) · The Lancet · doi:10.1016/s0140-6736(07)61835-2 · Cited by 458
Self-citationClinical trial registration: a statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17034-7 · Cited by 408
Evidence-based behavioral medicine: What is it and how do we achieve it?
Davidson, K. W., Goldstein, M., Kaplan, R. M., Kaufmann, P. G., Knatterud, G. L., Orleans, C. T., Spring, B., Trudeau, K. J., & Whitlock, E. P. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2603_01 · Cited by 408 · cited 1×
“For example, recently a group implemented the CONSORT Statement for behavioral medicine [19], although this implementation was not done in collaboration with the CONSORT Group.”
MethodEQUATOR: reporting guidelines for health research
Altman, D. G., Simera, I., Hoey, J., Moher, D., & Schulz, K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60505-x · Cited by 325
Self-citationBOUTRON, I., MOHER, D., TUGWELL, P., GIRAUDEAU, B., POIRAUDEAU, S., NIZARD, R., & RAVAUD, P. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.05.004 · Cited by 308
Self-citationEQUATOR: reporting guidelines for health research.
Altman, D. G., Simera, I., Hoey, J., Moher, D., & Schulz, K. (2008) · PubMed Central · Cited by 258
Self-citationBossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · PubMed · Cited by 242
Self-citationHopewell, S., Altman, D. G., Moher, D., & Schulz, K. F. (2008) · Trials · doi:10.1186/1745-6215-9-20 · Cited by 241 · cited 1×
“However, some journals have used inconsistent language to describe their endorsement [36–38], and this vagueness likely diminishes serious efforts to improve the quality of reporting within journals.”
BackgroundSelf-citationThe quality of diagnostic accuracy studies since the STARD statement: Has it improved?
Smidt, N., Rutjes, A. W. S., van der Windt, D. A. W. M., Ostelo, R. W. J. G., Bossuyt, P. M., Reitsma, J. B., Bouter, L. M., & de Vet, H. C. W. (2006) · Neurology · doi:10.1212/01.wnl.0000238386.41398.30 · Cited by 235
Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors
Simera, I., Altman, D. G., Moher, D., Schulz, K. F., & Hoey, J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050139 · Cited by 220 · cited 5×
“The majority of reporting guidelines have been limited to developing a checklist [24]; a few groups have also developed a flow diagram, the most well known of which is the CONSORT diagram.”
BackgroundInfluentialSelf-citationAltman, D. G. (2005) · BMJ · doi:10.1136/bmj.330.7499.1056 · Cited by 178 · cited 1×
“Some journals, those whose editors initially were involved in the guideline development, will be eager to support the use of the reporting guideline. This support can be most readily achieved when a journal endorses the reporting guideline. However, some journals have used inconsistent language to describe their endor…”
BackgroundSelf-citationPrady, S. L., Richmond, S. J., Morton, V. M., & MacPherson, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001577 · Cited by 145 · cited 1×
“While there is increasing evidence that use of reporting guidelines is associated with improvements in the quality of reporting health research [37,39,41,42], there is a growing anecdotal belief that reporting guidelines indirectly have a positive impact on how researchers design and conduct their research [43].”
BackgroundPublication Guidelines for Improvement Studies in Health Care: Evolution of the SQUIRE Project
Davidoff, F., Batalden, P., Stevens, D., Ogrinc, G., Mooney, S., & for the SQUIRE Development Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00009 · Cited by 130 · cited 1×
“individual guidelines were developed remains sparse [12,13] and”
BackgroundDavidoff, F., Batalden, P. B., Stevens, D., Ogrinc, G. S., Mooney, S. E., & for the SQUIRE development group (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0797-4 · Cited by 109
An assessment of the quality of randomised controlled trials conducted in China
Zhang, D., Yin, P., Freemantle, N., Jordan, R., Zhong, N., & Cheng, K. (2008) · Trials · doi:10.1186/1745-6215-9-22 · Cited by 75 · cited 1×
“This is just one of numerous examples of a large and disturbing literature indicating the general failure in the quality of reporting health research [2–6].”
BackgroundSmith, B. A., Lee, H.-J., Lee, J. H., Choi, M., Jones, D. E., Bausell, R. B., & Broome, M. E. (2008) · Nursing Outlook · doi:10.1016/j.outlook.2007.09.002 · Cited by 67 · cited 1×
“While there is increasing evidence that use of reporting guidelines is associated with improvements in the quality of reporting health research [37,39,41,42], there is a growing anecdotal belief that reporting guidelines indirectly have a positive impact on how researchers design and conduct their research [43].”
BackgroundAn international survey indicated that unpublished systematic reviews exist
Tricco, A. C., Pham, B., Brehaut, J., Tetroe, J., Cappelli, M., Hopewell, S., Lavis, J. N., Berlin, J. A., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.09.014 · Cited by 64
Self-citationBeyond CONSORT: Need for Improved Reporting Standards for Clinical Trials
Meinert, C. L. (1998) · JAMA · doi:10.1001/jama.279.18.1487 · Cited by 64 · cited 1×
“After the CONSORT Statement was originally published, Meinert [35] provided valuable suggestions on ways to improve the flow diagram and the clarity of some of the terminology initially used.”
MethodLai, T. Y. Y., Wong, V. W. Y., Lam, R. F., Cheng, A. C. O., Lam, D. S. C., & Leung, G. M. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580701344399 · Cited by 61
Narahari, S. R., Ryan, T. J., Aggithaya, M. G., Bose, K. S., & Prasanna, K. S. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.0818 · Cited by 61
Reporting research results: a moral obligation for all researchers.
Moher, D. (2007) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022653 · Cited by 60 · cited 1×
“There are also ethical and moral reasons for reporting research adequately [7].”
BackgroundSelf-citationAltman (2005) · doi:10.1016/s0025-7753(05)72203-x · Cited by 43
Scales, C. D., Norris, R. D., Preminger, G. M., Vieweg, J., Peterson, B. L., & Dahm, P. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.06.026 · Cited by 32 · cited 1×
“This is just one of numerous examples of a large and disturbing literature indicating the general failure in the quality of reporting health research [2–6].”
BackgroundDetails of patients' consent in studies should be reported
Nylenna, M. (1997) · BMJ · doi:10.1136/bmj.314.7087.1127 · Cited by 16
Research works printed but not linked: 3
- D Moher, Reporting Guidelines for Clinical Research: A Systematic Review. 6th International Congress on Peer Review and Biomedical Publication, Vancouver.
- LB O'Toole, 1997, MRC uses checklist similar to CONSORTs., BMJ, 314, 1127
- I Boutron, 2005, Reporting of nonpharmacologic treatment interventions: an extension of the CONSORT Statement., Ann Intern Med, 148, W-60
Cited by
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Self-citationPRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
“The PRISMA extension for scoping reviews (hereafter, the PRISMA-ScR) was 162 developed according to published guidance by the EQUATOR (Enhancing the QUAlity 163 and Transparency Of health Research) Network for the development of reporting 164 guidelines (9).”
MethodSelf-citationPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
“The process proposed by the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network was used to guide PRISMA-P development [27].”
MethodSelf-citationQUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Self-citation
Metadata
- Authors
- Moher, D., Schulz, K. F., Simera, I., & Altman, D. G.
- Affiliations
- University of Ottawa (CA)
- University of Oxford (GB)
- Corresponding author
- Moher, David
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-16
- Volume
- 7
- Issue
- 2
- Pages
- e1000217
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC2821895
- OpenAlex
- W2093038967
- Cited by
- 1,437
- References
- 64
- Citations by year
- 2026: 100 · 2025: 157 · 2024: 152 · 2023: 147 · 2022: 140 · 2021: 127 · 2020: 140 · 2019: 76 · 2018: 58 · 2017: 58 · 2016: 77 · 2015: 70 · 2014: 37 · 2013: 41 · 2012: 18
- FWCI
- 31.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Ottawa
- Cancer Research UK
- Medical Research Council (MC_qA137931)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Keywords
- reporting guidelines, health research, guideline development, EQUATOR Network, research transparency
- MeSH terms
- Humans, Publishing, Guidelines as Topic, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.